<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20536" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diphenhydramine Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huynh</surname>
            <given-names>David A.</given-names>
          </name>
          <aff>Beaumont Hospital, Dearborn</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abbas</surname>
            <given-names>Malak</given-names>
          </name>
          <aff>Corewell Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dabaja</surname>
            <given-names>Ali</given-names>
          </name>
          <aff>Beaumont Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>David Huynh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Malak Abbas declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ali Dabaja declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20536.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Diphenhydramine is most often used for the treatment of nausea, vomiting, allergic rhinitis, mild to severe allergic reactions (e.g., anaphylaxis), and as a mild sleep aid. However, due to easy access to this medication, it is often abused and can lead to acute intoxication. To avoid the potentially serious complications and mortality associated with diphenhydramine toxicity, it must be promptly diagnosed and treated. This activity describes the evaluation and management of diphenhydramine toxicity and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of diphenhydramine toxicity.</p></list-item><list-item><p>Review the appropriate evaluation of diphenhydramine toxicity.</p></list-item><list-item><p>Outline the management options available for diphenhydramine toxicity.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance diphenhydramine toxicity management and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20536&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20536">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20536.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Diphenhydramine is a first-generation antihistamine with anticholinergic and sedative properties. It is most commonly used for the treatment of nausea, vomiting, allergic rhinitis, mild to severe allergic reactions (e.g., anaphylaxis), and as a mild sleep aid. While used for a wide array of medical indications, diphenhydramine is also one of the most commonly abused medications in the United States (U.S.). Acute intoxication with diphenhydramine can have severe, potentially fatal consequences if not managed appropriately in a timely manner.<xref ref-type="bibr" rid="article-20536.r1">[1]</xref></p>
      </sec>
      <sec id="article-20536.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Diphenhydramine toxicity can occur via oral, topical, or intravenous administration. However, it is likely that toxic diphenhydramine exposures are a result of oral ingestion, given the accessibility of oral diphenhydramine compared to other diphenhydramine formulations. Diphenhydramine overdose or intoxication can be either accidental or intentional.<xref ref-type="bibr" rid="article-20536.r1">[1]</xref>&#x000a0;While intentional diphenhydramine overdose/intoxication can be observed in individuals attempting self-harm/suicide, there is documentation of individuals utilizing diphenhydramine to produce pleasant and euphoric effects.<xref ref-type="bibr" rid="article-20536.r2">[2]</xref><xref ref-type="bibr" rid="article-20536.r3">[3]</xref>&#x000a0;It is important to note that diphenhydramine can also be found in certain over-the-counter combination medications, such as those used for the treatment of coughs and colds.</p>
      </sec>
      <sec id="article-20536.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In 2016, a study demonstrated that diphenhydramine overdoses made up 3.2% of drug overdose deaths in the U.S. In the same study, diphenhydramine ranked among the top 15 drugs most frequently involved in drug overdose deaths in the U.S.<xref ref-type="bibr" rid="article-20536.r4">[4]</xref>&#x000a0;Most diphenhydramine intoxication/overdose cases occur in children ages 6 years or younger.<xref ref-type="bibr" rid="article-20536.r5">[5]</xref></p>
      </sec>
      <sec id="article-20536.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Diphenhydramine competes&#x000a0;against histamine to bind to H1-receptor sites on effector cells in the respiratory tract,&#x000a0;blood vessels, gastrointestinal tract, and CNS. Within the CNS, diphenhydramine can occupy, even at therapeutic doses, H1-receptors in the frontal cortex, temporal cortex, hippocampus, and pons. This can lead to significant sedation and can produce moderate to severe neurological and respiratory signs/symptoms characterized by intoxication and overdose.<xref ref-type="bibr" rid="article-20536.r1">[1]</xref><xref ref-type="bibr" rid="article-20536.r6">[6]</xref> Due to its effects on muscarinic receptors, diphenhydramine can produce anticholinergic effects, such as blurred vision, dry mouth, urinary retention, impotence, tachycardia, and gastrointestinal effects, such as nausea and constipation.<xref ref-type="bibr" rid="article-20536.r6">[6]</xref></p>
      </sec>
      <sec id="article-20536.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Diphenhydramine can also have negative cardiovascular consequences in the setting of toxicity. ECG changes can be observed, which include the widening of the QRS-complex and tachycardia, possibly caused by the anticholinergic effects of diphenhydramine. More specifically, diphenhydramine can affect the delayed rectifier potassium ion channels of the heart as it can act as a blocker of potassium channels. These channels are responsible for the rapid component of the cardiac repolarizing current. This leads to the prolongation of the QT interval and a flattening of the T-wave.<xref ref-type="bibr" rid="article-20536.r1">[1]</xref><xref ref-type="bibr" rid="article-20536.r6">[6]</xref><xref ref-type="bibr" rid="article-20536.r7">[7]</xref>&#x000a0;As a result, individuals are at increased risk of developing potentially fatal arrhythmias, such as torsade de pointes.</p>
        <p>Diphenhydramine pharmacokinetics do not appear to change in the event of intoxication/overdose.<xref ref-type="bibr" rid="article-20536.r8">[8]</xref>&#x000a0;Peak serum levels of diphenhydramine are reached approximately 2 to 3 hours after oral administration. The elimination half-life of diphenhydramine can vary between age groups. For pediatric patients, the elimination half-life is approximately 5 hours (range: 4 to 7 hours). For adult patients, the elimination half-life is approximately 9 hours (range: 7 to 12 hours) and approximately 13.5 hours (range: 9 to 18 hours) for elderly patients (range: 9 to 18 hours).<xref ref-type="bibr" rid="article-20536.r9">[9]</xref>&#x000a0;Diphenhydramine is lipophilic and has a relatively large volume of distribution (Vd).</p>
        <p>Vd can also vary between age groups. For pediatric patients, the Vd is approximately 22 L/kg (range: 15 to 28 L/kg). For adult patients, the Vd is approximately 17 L/kg (range: 13 to 20 L/kg) and approximately 14 L/kg (range: 7 to 20 L/kg) for elderly patients.<xref ref-type="bibr" rid="article-20536.r9">[9]</xref><xref ref-type="bibr" rid="article-20536.r10">[10]</xref>&#x000a0;It is extensively metabolized by the liver via cytochrome P450 enzymes. Most of the diphenhydramine that is hepatically metabolized undergoes N-demethylation via CYP2D6, with minor demethylation occurring via CYP1A2, CYP2C9, AND CYP2C19. The drug undergoes metabolism to much smaller degrees in the pulmonary and renal system and is, thus, minimally removed by hemodialysis.<xref ref-type="bibr" rid="article-20536.r8">[8]</xref><xref ref-type="bibr" rid="article-20536.r9">[9]</xref><xref ref-type="bibr" rid="article-20536.r11">[11]</xref>&#x000a0;Studies have shown that diphenhydramine toxicity is dose-dependent. One retrospective study observed that moderate symptoms, characterized as agitation, confusion, hallucinations, and ECG disturbances, occurred at doses of 0.3 grams. Furthermore, severe symptoms, characterized as delirium/psychosis, seizures, coma, and death, manifested at doses of 1 gram or more.<xref ref-type="bibr" rid="article-20536.r12">[12]</xref></p>
      </sec>
      <sec id="article-20536.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with diphenhydramine toxicity present with an extension of adverse effects and generally include CNS depression and anticholinergic symptoms. Patients that present with mild to moderate poisoning exhibit more anticholinergic symptoms, which include dry mucous membranes, disorientation, tachycardia, mydriasis, urinary retention, hyperthermia, and decreased bowel sounds. Patients with more severe toxicity may also have severe delirium, seizures, psychosis, hypotension, dystonic reactions, hallucinations, and cardiac arrhythmias (i.e., QT prolongation and QRS prolongation). In rare cases, there are reports of rhabdomyolysis and renal failure in patients with prolonged agitation, coma, or seizures.</p>
      </sec>
      <sec id="article-20536.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>An assessment utilizing the ABCDE (airway, breathing, circulation, disability, exposure) approach should be performed upon initial presentation to assess the severity of intoxication/overdose quickly. Vital signs, including blood pressure, heart rate, respiratory rate, temperature, and oxygen saturation, should be obtained to aid in this initial assessment. An EKG should be obtained and assessed for any changes that may indicate the presence of any arrhythmias (e.g., torsades de pointes). An acetaminophen level should also be obtained to either confirm or rule out acetaminophen as a coingestant.</p>
        <p>Diphenhydramine plasma levels do not provide any relevant clinical information and are also not readily available. Furthermore, despite undergoing extensive hepatic metabolism, diphenhydramine is not expected to cause any abnormal elevations in liver function tests or be linked to liver injury.<xref ref-type="bibr" rid="article-20536.r13">[13]</xref> Serum creatinine, urine output, and creatine phosphokinase should be obtained to rule out rhabdomyolysis in the setting of seizure.</p>
      </sec>
      <sec id="article-20536.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>If the patient presents within 1 hour of ingestion of diphenhydramine, decontamination techniques may be considered. Single-dose activated charcoal may benefit, especially as anticholinergic effects may result in decreased gastrointestinal motility leading to delayed absorption of diphenhydramine. However, the use of charcoal is avoided in patients with altered mental status unless the airway is protected.<xref ref-type="bibr" rid="article-20536.r14">[14]</xref><xref ref-type="bibr" rid="article-20536.r15">[15]</xref><xref ref-type="bibr" rid="article-20536.r16">[16]</xref>&#x000a0;Other decontamination procedures such as ipecac, cathartics, or gastric lavage have not been proven to be beneficial or routinely used due to a lack of demonstrated efficacy and increased risk of complications.<xref ref-type="bibr" rid="article-20536.r17">[17]</xref><xref ref-type="bibr" rid="article-20536.r18">[18]</xref><xref ref-type="bibr" rid="article-20536.r19">[19]</xref><xref ref-type="bibr" rid="article-20536.r20">[20]</xref><xref ref-type="bibr" rid="article-20536.r21">[21]</xref><xref ref-type="bibr" rid="article-20536.r22">[22]</xref></p>
        <p>There is currently no antidote that specifically works to reverse the effects of diphenhydramine toxicity. The mainstay of therapy for diphenhydramine toxicity is supportive management that addresses the symptomatology of intoxication/overdose. Benzodiazepines (e.g., lorazepam) for seizures or convulsions, sodium bicarbonate for ventricular arrhythmia, and VA-ECMO for hemodynamic support can be used for the management of the clinical manifestations of diphenhydramine toxicity. Physostigmine has been used for acetylcholinesterase inhibition, but it is not currently available. There is growing support for the utilization of intravenous lipid emulsion therapy; however, its efficacy in this setting remains controversial. Diphenhydramine is minimally dialyzable, and thus, there is little support for hemodialysis in the management of diphenhydramine toxicity.<xref ref-type="bibr" rid="article-20536.r6">[6]</xref><xref ref-type="bibr" rid="article-20536.r23">[23]</xref><xref ref-type="bibr" rid="article-20536.r24">[24]</xref><xref ref-type="bibr" rid="article-20536.r25">[25]</xref><xref ref-type="bibr" rid="article-20536.r26">[26]</xref><xref ref-type="bibr" rid="article-20536.r15">[15]</xref><xref ref-type="bibr" rid="article-20536.r27">[27]</xref><xref ref-type="bibr" rid="article-20536.r28">[28]</xref></p>
        <p>In pediatric cases, ingested diphenhydramine dose less than 7.5 mg/kg is safe for home observation. However, patients demonstrating any behavioral changes other than mild drowsiness or mild stimulation should be referred to an emergency department. Pediatric ingestions of diphenhydramine more than 7.5 mg/kg&#x000a0;require referral to a healthcare facility.<xref ref-type="bibr" rid="article-20536.r15">[15]</xref></p>
      </sec>
      <sec id="article-20536.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis should include any substance or condition that may alter mentation, result in tachycardia, urinary retention, seizures, or other anticholinergic effects. Other organic processes should also be included, such as meningitis or sepsis. To help with ruling out causes, the time of onset of delirium is important. Toxin-induced delirium occurs more rapidly and abruptly than organic causes. In patients with altered mental status, hyperthermia, and agitation, salicylate toxicity should also be ruled out.</p>
      </sec>
      <sec id="article-20536.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Given early identification and management in a timely manner, the prognosis for diphenhydramine toxicity or overdose is good. Recovery is likely; however, complications may occur from prolonged hospital stays, such as pneumonia. Therefore, patients may be considered for discharge if they remain asymptomatic beyond four hours of diphenhydramine oral exposure or eight hours if dermal exposure. However, a patient may be admitted if they display moderate to severe signs of anticholinergic toxicity.</p>
      </sec>
      <sec id="article-20536.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Respiratory failure</p>
          </list-item>
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
          <list-item>
            <p>Cardiac arrest</p>
          </list-item>
          <list-item>
            <p>Rhabdomyolysis</p>
          </list-item>
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20536.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Education to both the patients and the parents of pediatric patients about the proper use of medication is important. Parents should be educated not to use diphenhydramine in children younger than 12 years of age without the direction of a physician. Patients should also be educated about over-the-counter products containing diphenhydramine and other anticholinergic medications.</p>
      </sec>
      <sec id="article-20536.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>In patients with severe toxicity, a consult with a medical toxicologist or poison control center may be beneficial. If intoxication or overdose occurred accidentally, patient or caregiver education is key to decrease repeated episodes. Proper storage techniques and the utilization of children-proof containers should be emphasized to keep medications out of the reach of children, given most incidences are pediatric. Collaboration with emergency medicine pharmacists might be beneficial as they can recommend appropriate supportive therapy and identify any drug-drug interactions as well. Concomitant administration of diphenhydramine with other medications that can also cause sedation or respiratory depression should be avoided. &#x000a0;</p>
        <p>If intoxication or overdose occurred with the intention of self-harm, psychiatric services should be consulted as part of inpatient care. Referral to outpatient behavioral health resources prior to discharge would also be warranted to mitigate the risk of repeated intoxication or overdose.</p>
      </sec>
      <sec id="article-20536.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20536&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20536">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/medications/diphenhydramine-toxicity-benadryl-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20536">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20536/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20536">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20536.s16">
        <title>References</title>
        <ref id="article-20536.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eckes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tsokos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Herre</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gapert</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hartwig</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Toxicological identification of diphenhydramine (DPH) in suicide.</article-title>
            <source>Forensic Sci Med Pathol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-53</page-range>
            <pub-id pub-id-type="pmid">23065653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gardner</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kutcher</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Dimenhydrinate abuse among adolescents.</article-title>
            <source>Can J Psychiatry</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-6</page-range>
            <pub-id pub-id-type="pmid">8467436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rowe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Verjee</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Adolescent dimenhydrinate abuse: resurgence of an old problem.</article-title>
            <source>J Adolesc Health</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-9</page-range>
            <pub-id pub-id-type="pmid">9215510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hedegaard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bastian</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Trinidad</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016.</article-title>
            <source>Natl Vital Stat Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>67</volume>
            <issue>9</issue>
            <fpage>1</fpage>
            <page-range>1-14</page-range>
            <pub-id pub-id-type="pmid">30707673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mowry</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Spyker</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Cantilena</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>McMillan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>10</issue>
            <fpage>1032</fpage>
            <page-range>1032-283</page-range>
            <pub-id pub-id-type="pmid">25559822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wakai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inokuchi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cardiac arrest caused by diphenhydramine overdose.</article-title>
            <source>Acute Med Surg</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>380</fpage>
            <page-range>380-383</page-range>
            <pub-id pub-id-type="pmid">30338086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taglialatela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Timmerman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Annunziato</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Cardiotoxic potential and CNS effects of first-generation antihistamines.</article-title>
            <source>Trends Pharmacol Sci</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>52</fpage>
            <page-range>52-6</page-range>
            <pub-id pub-id-type="pmid">10664607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Elimination half-life of diphenhydramine in overdose.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>615</fpage>
            <page-range>615-616</page-range>
            <pub-id pub-id-type="pmid">28349707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simons</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Simons</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children.</article-title>
            <source>J Clin Pharmacol</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>665</fpage>
            <page-range>665-71</page-range>
            <pub-id pub-id-type="pmid">2391399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blyden</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Greenblatt</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Scavone</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shader</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration.</article-title>
            <source>J Clin Pharmacol</source>
            <year>1986</year>
            <season>Sep-Oct</season>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>529</fpage>
            <page-range>529-33</page-range>
            <pub-id pub-id-type="pmid">3760245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akutsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakurada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ikegaya</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Furihata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chiba</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.</article-title>
            <source>Drug Metab Dispos</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-8</page-range>
            <pub-id pub-id-type="pmid">17020955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radovanovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Guirguis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lorent</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kupferschmidt</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Dose-dependent toxicity of diphenhydramine overdose.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>489</fpage>
            <page-range>489-95</page-range>
            <pub-id pub-id-type="pmid">11204550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <chapter-title>Diphenhydramine</chapter-title>
            <source>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</source>
            <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2017</year>
            <month>1</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">31643789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chyka</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Seger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krenzelok</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>JA</given-names>
              </name>
              <collab>American Academy of Clinical Toxicology</collab>
              <collab>European Association of Poisons Centres and Clinical Toxicologists</collab>
            </person-group>
            <article-title>Position paper: Single-dose activated charcoal.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2005</year>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>61</fpage>
            <page-range>61-87</page-range>
            <pub-id pub-id-type="pmid">15822758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scharman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Erdman</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Wax</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Chyka</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Caravati</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Manoguerra</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Christianson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Woolf</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Keyes</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Booze</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Troutman</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Diphenhydramine and dimenhydrinate poisoning: an evidence-based consensus guideline for out-of-hospital management.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2006</year>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-23</page-range>
            <pub-id pub-id-type="pmid">16749537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <article-title>Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1999</year>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>731</fpage>
            <page-range>731-51</page-range>
            <pub-id pub-id-type="pmid">10584586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <article-title>Position paper: cathartics.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2004</year>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>243</fpage>
            <page-range>243-53</page-range>
            <pub-id pub-id-type="pmid">15362590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <article-title>Position paper: Ipecac syrup.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2004</year>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-43</page-range>
            <pub-id pub-id-type="pmid">15214617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <article-title>Position paper: whole bowel irrigation.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2004</year>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>843</fpage>
            <page-range>843-54</page-range>
            <pub-id pub-id-type="pmid">15533024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000f6;jer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Troutman</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Hoppu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Erdman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>M&#x000e9;garbane</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thanacoody</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bedry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caravati</surname>
                <given-names>EM</given-names>
              </name>
              <collab>American Academy of Clinical Toxicology</collab>
              <collab>European Association of Poison Centres and Clinical Toxicologists</collab>
            </person-group>
            <article-title>Position paper update: ipecac syrup for gastrointestinal decontamination.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>134</fpage>
            <page-range>134-9</page-range>
            <pub-id pub-id-type="pmid">23406298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benson</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Hoppu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Troutman</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Bedry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Erdman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>H&#x000f6;jer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>M&#x000e9;garbane</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thanacoody</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caravati</surname>
                <given-names>EM</given-names>
              </name>
              <collab>American Academy of Clinical Toxicology</collab>
              <collab>European Association of Poisons Centres and Clinical Toxicologists</collab>
            </person-group>
            <article-title>Position paper update: gastric lavage for gastrointestinal decontamination.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>140</fpage>
            <page-range>140-6</page-range>
            <pub-id pub-id-type="pmid">23418938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vale</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kulig</surname>
                <given-names>K</given-names>
              </name>
              <collab>American Academy of Clinical Toxicology</collab>
              <collab>European Association of Poisons Centres and Clinical Toxicologists</collab>
            </person-group>
            <article-title>Position paper: gastric lavage.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>2004</year>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>933</fpage>
            <page-range>933-43</page-range>
            <pub-id pub-id-type="pmid">15641639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Manini</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Trueger</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Duque</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nestor</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus and wide-complex tachycardia secondary to diphenhydramine overdose.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>945</fpage>
            <page-range>945-8</page-range>
            <pub-id pub-id-type="pmid">21171853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamijo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Soma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kurihara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Fatal diphenhydramine poisoning with increased vascular permeability including late pulmonary congestion refractory to percutaneous cardiovascular support.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>9</issue>
            <fpage>864</fpage>
            <page-range>864-8</page-range>
            <pub-id pub-id-type="pmid">18608279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Hexdall</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate.</article-title>
            <source>Am J Emerg Med</source>
            <year>2003</year>
            <month>May</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>212</fpage>
            <page-range>212-5</page-range>
            <pub-id pub-id-type="pmid">12811715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burns</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Linden</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Graudins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.</article-title>
            <source>Ann Emerg Med</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>374</fpage>
            <page-range>374-81</page-range>
            <pub-id pub-id-type="pmid">10736125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diphenhydramine overdose with intraventricular conduction delay treated with hypertonic sodium bicarbonate and i.v. lipid emulsion.</article-title>
            <source>West J Emerg Med</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>855</fpage>
            <page-range>855-8</page-range>
            <pub-id pub-id-type="pmid">25493135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20536.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Intravenous lipid-emulsion therapy in a patient with cardiac arrest after overdose of diphenhydramine.</article-title>
            <source>J Formos Med Assoc</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>115</volume>
            <issue>11</issue>
            <fpage>1017</fpage>
            <page-range>1017-1018</page-range>
            <pub-id pub-id-type="pmid">27421174</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
